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Protective Role of Interleukin-6 during Yersinia enterocolitica Infection
Is Mediated through the Modulation of Inflammatory Cytokines
Peter H. Dube,1† Scott A. Handley,1†‡ James Lewis,2,3 and Virginia L. Miller1,4*
Department of Molecular Microbiology,1 Department of Medicine,2 Department of Pathology and Immunology,3 and
Department of Pediatrics,4 Washington University School of Medicine, St. Louis, Missouri 63110
Received 4 August 2003/Returned for modification 30 September 2003/Accepted 22 February 2004
Yersinia enterocolitica is a gram-negative enteric pathogen responsible for a number of gastrointestinal
disorders. A striking feature of the pathology of a Y. enterocolitica infection is inflammation. Recently, we
demonstrated a role for interleukin-1 (IL-1) in the establishment of intestinal inflammation in response to
a Y. enterocolitica infection. A cytokine directly affected by IL-1 levels is IL-6. A previous report suggested that
IL-6 plays an anti-inflammatory role during Y. enterocolitica infection, and in other systems IL-6 has been
shown to be proinflammatory. Therefore, a closer examination of the roles of IL-6 and inflammatory cytokines
in the control of Y. enterocolitica infection in IL-6/ mice was undertaken. Y. enterocolitica organisms were more
virulent in the IL-6/ mice (60-fold decreased 50% lethal dose) and colonized systemic tissues more rapidly
and to a higher level than in the wild-type mice. One role of IL-6 during a Y. enterocolitica infection may be the
downmodulation of the inflammatory response. The IL-6/ mice have a more robust TH1 T-cell response, as
well as hyperinflammatory pathologies. These phenotypes appear to be due to the misregulation of tumor
necrosis factor alpha, monocyte chemotactic protein 1, IL-10, transforming growth factor 1, and gamma
interferon in the IL-6/ mouse. These data provide further insight into the intricate cytokine signaling
pathways involved in the regulation of inflammatory responses and the control of bacterial infections.
There are three species within the genus Yersinia that are
pathogenic for humans. These include the two enteric patho-
gens Yersinia enterocolitica and Y. pseudotuberculosis, as well as
Y. pestis the plague bacillus. The diseases caused by these
bacteria are varied, ranging from gastroenteritis and lymphad-
enitis to both bubonic and pneumonic plague (6, 25). Infection
of healthy individuals with Y. enterocolitica is usually self-lim-
iting, resulting in gastrointestinal disease (31). A typical Y. en-
terocolitica infection is the result of consuming contaminated
food or water. The bacteria are capable of surviving the harsh
environment of the stomach and travel to the small intestine,
where they attach to and invade the lymphoid follicles of the
small intestine called Peyer’s patches (PP). Once inside the PP
the bacteria are mainly extracellular pathogens capable of rep-
licating to high numbers (109 CFU/g of tissue). Subsequently,
if systemic disease is established, the bacteria can disseminate
to deeper tissues, such as the mesenteric lymph nodes (MLN),
spleen, liver, and lung. A consequence of Y. enterocolitica in-
fection is acute inflammation.
The murine model of Y. enterocolitica infection has proven
extremely valuable for gaining a greater understanding of the
cytokine responses to bacterial pathogens. This model of yersi-
niosis mimics all aspects of disease observed in humans, in-
cluding systemic disease (8–11). To date, a role during the host
response to Y. enterocolitica has been demonstrated in the
murine model for interleukin-1 (IL-1), IL-1 receptor antago-
nist (IL-1ra), IL-6, IL-10, IL-12, IL-18, monocyte chemotactic
protein 1 (MCP-1), gamma interferon (IFN-), and tumor
necrosis factor alpha (TNF-) (2, 3, 5, 14, 15, 17, 29).
Using Y. enterocolitica as a model for studying yersiniosis in
vivo, we recently demonstrated that IL-1 is important for
initiating early intestinal inflammatory responses (14). During
these experiments and a subsequent analysis of the host re-
sponse by genome scale transcriptional profiling (GeneChips),
a role for IL-6 in the regulation of the inflammatory response
was suggested that was more involved than previously reported
(17; S. A. Handley et al., unpublished data).
IL-6 is a multifunctional cytokine that has been described to
have both pro- and anti-inflammatory effects, as well as being
involved in a variety of immune responses. Like IL-1 and
TNF-, IL-6 is an inflammatory cytokine (21). IL-6 plays a
major role in the elaboration of the acute-phase responses (21,
22). In addition, IL-6 is involved in B-cell proliferation (20, 30).
In the context of a Y. enterocolitica infection, IL-6 has an
anti-inflammatory function through feedback inhibition of the
IL-1 signaling pathway via the induction of IL-1ra (17, 27).
Recent evidence demonstrates that IL-6, in conjunction with
soluble IL-6 receptor, mediates the switch from the early neu-
trophilic inflammatory response to the sustained monocytic re-
sponse (16). In addition, recent data have demonstrated a role
for IL-6 in the cellular immune response by inhibiting the dif-
ferentiation of activated CD4 T cells to the TH1 phenotype (13).
IL-6 provides protection during infection with the intracel-
lular bacterial pathogens Listeria monocytogenes and Mycobac-
terium tuberculosis (22, 23), but the exact mechanism for the
protective role of IL-6 during a bacterial infection is not fully
understood. We provide here evidence for a protective role of
IL-6 during Y. enterocolitica infection. IL-6 protection appears
to be mediated through the action of several immunomodula-
tory cytokines (IL-10, MCP-1, TNF-, IFN-, and transform-
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ing growth factor 1 [TGF-1]), in addition to the established
role for IL-1ra (17). Our data suggest that the in vivo misregu-
lation of these cytokines in the IL-6/ mouse leads to a defect
in the regulation of inflammatory responses and, ultimately, to
a hyperinflammatory phenotype, severe sepsis, and increased
mortality.
MATERIALS AND METHODS
Mice. Female C57BL/6j and C57BL/6j–IL-6tm1Kopf mice (hereafter referred to
as IL-6/ mice) 6 to 8 weeks of age were purchased from Jackson Laboratory
and maintained in the barrier facility at Washington University School of Med-
icine. Mice were given free access to food and water throughout all experiments.
Animals were sacrificed by carbon dioxide asphyxiation. The Washington Uni-
versity committee on animal studies approved all animal experiments.
Bacteria. The Y. enterocolitica strain used in the present study (JB580v) is a
virulent derivative of the serogroup O8 strain 8081 (19). Bacteria were grown
overnight in Luria-Bertani (LB) broth at 26°C. Actual numbers of CFU were de-
termined by serial dilutions of the overnight culture, followed by plating on LB agar.
LD50 (50% lethal dose) and kinetics analysis. Bacteria were grown 16 to 18 h
in LB at 26°C. Five groups of six mice were infected orally with successive 10-fold
dilutions of the bacterial suspension (104-109 bacteria). The mice were moni-
tored twice daily for 14 days. This analysis was done in duplicate. The LD50
values were determined according to the method of Reed and Muench (26).
Kinetics of infection analysis was done by orally infecting mice with the indicated
dose of strain JB580v (19). At various times postinfection (1, 3, or 7 days), mice
from each strain were sacrificed and dissected. Bacterial loads recovered from
the infected organs were determined by plating dilutions of the macerated tissues
on LB plates containing 20 g of nalidixic acid/ml to select for Y. enterocolitica
and are reported as CFU per gram of tissue. This analysis was done in duplicate.
Peritoneal macrophages. C57BL/6j or IL-6/ mice were injected intraperi-
toneally with 3 ml of a sterile lipopolysaccharide (LPS)-free 2% starch solution.
All materials used in these studies for tissue culture or in vivo were certified to
be “low endotoxin” by the vendor. After 4 days the mice were sacrificed, and the
peritoneal cavities were washed with Dulbecco modified Eagle medium contain-
ing 10% fetal calf serum. Peritoneal exudate cells were collected and plated in
appropriate culture dishes at a cellular concentration appropriate for the given
assay. After 4 h, the cells were extensively washed with phosphate-buffered saline
(PBS) to remove the nonadherent cells and then maintained in Dulbecco mod-
ified Eagle medium–10% fetal calf serum until use.
Histopathology. Mice of the specified genotype were infected orally with the
indicated amounts of strain JB580v. On days 1, 3, and 7 postinfection the mice
were sacrificed, and the small intestines, MLN, spleens, and livers were removed.
The lumen of the intestine was flushed with PBS, and then tissues were fixed in
10% neutral buffered formaldehyde prior to being embedded in paraffin and
stained with hematoxylin and eosin. Slides were investigated in a blind fashion by
two independent investigators. Tissues were scored on a scale of 0 to 4, with 0
being a pathology consistent with the mock-infected control tissues and 4 being
the most severe pathology observed. Dead mice were excluded from analysis.
ELISA and CBA. Splenocytes from infected mice, at 105 cells/well, from the
indicated mouse genotype were prepared as described and plated in 96-well
plates. Briefly, mice were infected orally with Y. enterocolitica strain JB580v, and
the infection was allowed to proceed for the indicated amount of time before
spleens and sera were harvested. Single-cell splenocyte cultures were plated at
the indicated cell densities. Assay plates were then centrifuged at 1,000  g for
5 min, and the culture supernatant was removed and frozen at 80°C until use.
TGF-1, IFN-, IL-6, and IL-10 capture enzyme-linked immunosorbent assay
(ELISA) kits were purchased from Pharmingen, and experiments were per-
formed according to the manufacturer’s instructions. The results are the average
of four assays done in duplicate. For assays done on serum, mice were bled at the
indicated times after infection, and the serum was frozen at 80°C until use.
Cytometric bead array (CBA) analysis (mouse inflammation arrays [Pharmin-
gen] specific for IL-6, IL-10, MCP-1, TNF-, IFN-, and IL-12p70) was done on
serum, and splenocyte supernatants were prepared as described for the ELISA
analysis according to the manufacturer’s instructions.
For assays in which cytokine levels were determined directly from spleen
homogenates, mice were infected and spleens were harvested as described above.
Single-cell splenocyte suspensions were then subjected to four rounds of freeze-
thaw, and the suspensions cleared by centrifugation. Cleared supernatants were
used in CBA analysis to determine cytokine levels as described above. The
results in Table 3 are the average of two experiments. Five mice per treatment
group were used per experiment.
IL-6/ phenotype rescue. The IL-6 reconstitution experiments were done as
described by Diehl et al. (12). IL-6/ mice infected with Y. enterocolitica (108
CFU) were injected subcutaneously (s.c.) with 1 g of recombinant human IL-6
(Peprotech) for 5 days. The splenocytes were then harvested and used in ELISA
or CBA assays. Control C57BL/6j and IL-6/ mice were injected with a mock
injection of PBS. Both the recombinant human IL-6 and the PBS vector were
certified to be endotoxin free by the manufacturer of the product (i.e., with 0.1
ng of endotoxin/g). To determine whether the hyperinflammatory phenotype
could be rescued, mice given the indicated treatment were orally infected with
109 CFU of Y. enterocolitica. IL-6/ mice (10 per experimental group) were also
treated with rIL-6 as described above for 3 days and then sacrificed for his-
topathologic analysis. Tissues were prepared as described above and scored in a
blind manner by two independent investigators. Spleens from C57BL/6j mice,
IL-6/ mice, and IL-6/ mice that received 1 g of recombinant human IL-6
s.c. were scored for the inflammatory lesions.
Cytotoxicity assays. Nonradioactive cytotoxicity assays were performed by
using the CYTO-TOX 96 kit from Promega. Assays and controls were performed
as recommended by the manufacturer’s instructions. Briefly, peritoneal macro-
phages served as antigen-presenting cells (APC) and were plated in 96-well
culture dishes at a density of 105 cells/well. APC (target cells) were loaded with
antigen (10 ng of heat-killed Y. enterocolitica) overnight as previously described
(4) and then washed prior to the addition of 105 splenocytes to the well. The
cytotoxicity of the target cells was determined spectrophotometrically by en-
zymatic analysis of lactate dehydrogenase release. Specific lysis was calculated
as follows: % cytotoxicity 	 (EEsp  Tasp)/Tamax  Tasp), where EEsp is spon-
taneous experimental effector, Tasp is spontaneous target, and Tamax is target
maximum. The results are the average of four assays done in duplicate.
Statistical analysis. Data were analyzed by using the Mann-Whitney test (a
two-tailed nonparametric analysis of variance [ANOVA]). This test assigns a
statistically significant P value if P is 0.02. Statistically significant comparisons
are indicated where appropriate.
RESULTS
IL-6 is protective during murine yersiniosis. Previous evi-
dence suggested that IL-6 has a protective role during bacterial
infection (22, 23). Thus, the ability of IL-6 to confer protection
against a Y. enterocolitica infection was directly assessed by
using 50% lethal dose (LD50) analysis. IL-6
/ mice and the
congenic C57BL/6j strain of mice were infected with various
doses of Y. enterocolitica, and the LD50 values were deter-
mined. IL-6/ mice had an LD50 60-fold lower than the
C57BL/6j mice: 5  105 CFU for the IL-6/ mice versus 3 
107 CFU for the C57BL/6j mice (Fig. 1A). These data suggest
that the IL-6/ mice have a defect in their ability to control a
Y. enterocolitica infection.
A kinetic analysis of Y. enterocolitica infection also demon-
strated a defect in the ability of IL-6/ mice to control Y.
enterocolitica infection (Fig. 1B). IL-6/ mice and C57BL/6j
mice were infected orally with 109 CFU of Y. enterocolitica.
The mice were then sacrificed at the indicated time, and the
extent of bacterial colonization was determined in the PP,
MLN, and spleen of each animal. After infection, there was
consistent colonization of the PP and MLN in both mouse
strains. There was a statistically significant difference in the day
3 PP and the day 7 MLN (P	 0.02). The IL-6/ mice showed
a more pronounced systemic spread by day 3 compared to the
C57BL/6j mice. This is most clearly demonstrated by the early
and consistent colonization of the spleen by the bacteria. It
should be noted that many of the IL-6/ mice destined for the
day 7 time point died prior to day 7 (7 of 12 IL-6/ mice died
prior to day 7 compared to 2 of 12 C57BL/6j mice). Death and
dissemination of the bacteria to the spleen are signs of systemic
yersiniosis that is more severe in the IL-6/ mice. This more
rapid colonization phenotype was also observed in IL-6/
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mice inoculated with 10-fold-fewer bacteria than the C57BL/6j
mice (data not shown).
IL-6/ mice have a hyperinflammatory phenotype. The
most striking pathological phenotype observed during acute
yersiniosis due to infection with the enteropathogenic yersiniae
is acute inflammation. Inflammation is part of the normal
response to infection and is usually an effective part of the
innate immune response to Y. enterocolitica infection. The in-
flammatory response to Y. enterocolitica infection is mediated
by inflammatory cytokines (IL-1 and TNF-) (2, 5, 14). During
infection of C57BL/6j mice with Y. enterocolitica, there is an
increase in IL-6 mRNA, as determined by quantitative real-
time PCR and microarray analysis, as well as an increase in
IL-6 levels in serum (Handley et al., unpublished) (Table 2).
Because IL-6 has been suggested to have an anti-inflammatory
role during Y. enterocolitica infection (17), it was hypothesized
that infection would lead to a strong inflammatory response in
the Y. enterocolitica-infected IL-6/ mouse. Consistent with
this hypothesis, gross examination suggested that the IL-6/
mice had a more severe inflammatory pathology after infection
with Y. enterocolitica. IL-6/ mice infected with Y. enteroco-
litica had more pronounced visible abscesses of the PP, MLN,
spleen, and liver earlier and at a greater frequency than did the
C57BL/6j mice (data not shown). Gastrointestinal bleeding
was common with the IL-6/, mice as were intestinal adhe-
sions. These are uncommon findings with the C57BL/6j mouse
(data not shown) at the time points examined.
To investigate the pathology further, a detailed histopatho-
logic analysis was done that compared IL-6/ and C57BL/6j
mice infected with Y. enterocolitica. Both strains of mice were
infected orally with 109 CFU of Y. enterocolitica. The mice
were then sacrificed on the indicated day, and tissues were
removed for histological analysis. Two independent investiga-
tors examined the slides in a blind fashion. Consistent with the
results obtained during the kinetic analysis, the microscopic
pathology of PP did not show any significant differences (data
not shown), both strains of mice had severe inflammatory pa-
thologies in the PP. However, examination of the deeper tis-
sues (MLN, spleen, and liver) revealed several important dif-
ferences. The IL-6/ mice had inflammatory pathologies more
frequently than the C57BL/6j mice. It should also be noted that
there was a higher mortality rate for the IL-6/ mice. Many of
the mice destined for the day 7 time point died prior to day 7
(60% for the IL-6/ mice compared to 20% for the C57BL/6j
mice). Presumably, these mice had significant pathology, how-
ever, these mice were excluded from examination, since the
exact time of death could not always be determined.
Pathological evidence of early systemic yersiniosis was fre-
quently observed in the IL-6/ mice. Fibrin thrombi with
hepatic ischemia were evident as early as day 3 in the IL-6/
mice (Fig. 2B). Fibrin thrombi in the liver were not observed
until day 7 in the wild-type mice (Fig. 2C). Fibrin thrombi were
FIG. 1. IL-6/ mice are deficient in the control of a Y. enteroco-
litica infection. (A) C57BL/6j or IL-6/ mice (five mice per dose)
were infected orally with a 10-fold serial dilutions (109 to 104 CFU) of
Y. enterocolitica and then monitored for death over a 14-day period.
The LD50 was calculated by the method of Reed and Muench (26). (B)
Kinetic analysis of infection. IL-6/ or C57BL/6j mice were infected
orally with 109 CFU of Y. enterocolitica. The infection was allowed to
proceed for the indicated amount of time. Mice were then sacrificed,
and the indicated organs were harvested. The bacterial load was de-
termined by enumerating the number of viable bacteria in each organ.
Each point on the scatter plot represents data from an individual
mouse. Points on the x axis represent tissues from mice that survived
to that time point but did not have recoverable bacteria. The median
for each data set is indicated with a horizontal bar, and asterisks
represent statistically significant comparisons as determined by a
Mann-Whitney nonparametric two-tailed ANOVA (day 3 PP, P 	
0.02; day 7 MLN, P 	 0.008). The results are the average of two
independent experiments.
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frequently observed in the spleens of the IL-6/ mice starting
at day 3 but were never observed in the spleens of the wild-type
mice at the times examined.
The inflammatory lesions of the IL-6/ mice were predomi-
nantly neutrophilic, whereas the inflammatory lesions of C57BL/
6j mice were largely neutrophilic but also contained macro-
phages. The neutrophilic nature of the response was best ob-
served in the microabscesses (infiltrates of inflammatory cells
without visible bacterial colonization [Fig. 2E]) and the micro-
colonies (infiltrates of inflammatory cells with visible bacterial
colonization) of the IL-6/ mice. The neutrophilic nature of
the inflammatory lesions is consistent with the hypothesis that
IL-6 mediates the transition from neutrophilic to monocytic
inflammatory lesions. In addition, these mice developed these
pathologies at earlier time points, more frequently, and to a
greater extent than the C57BL/6j mice. At early time points the
infiltrates are well defined and clearly neutrophilic. As disease
progresses, the infiltrates contain increasing amounts of cellu-
lar debris and Y. enterocolitica becomes microscopically evi-
dent. At latter time points both lymphocytes and macrophages
are present at sites of inflammation, although the lesions re-
main mostly neutrophilic. Furthermore, these pathologies were
present in organs from the IL-6/ mice not usually affected
during infection of the C57BL/6j mouse such as the pancreas (Fig.
2E), suggesting a broader systemic spread. Altogether, these
data suggest that the IL-6/ mice have a defect in the control
of the inflammatory response to Y. enterocolitica in conjunction
with an inability to control the bacterial infection.
IL-6/ mice infected with Y. enterocolitica have a stronger
inflammatory cytokine response than do C57BL/6j mice. The
resolution of a Y. enterocolitica infection ultimately depends on
the establishment of an adequate TH1 T-cell response (4). The
most significant cytokine in establishing a TH1 type T-cell re-
sponse is IFN-. IFN- is involved in the activation of inflam-
matory cells, and it has been well documented that IFN- has
a critical role in the control of Y. enterocolitica infection (1, 2).
Due to the histopathology of Y. enterocolitica-infected IL-6/
mice, it was of interest to examine IFN- levels from the tissues
of infected mice. IL-6/ mice and C57BL/6j mice were in-
fected with Y. enterocolitica, and the infection was allowed to
progress for 5 days. Mice were then sacrificed, and spleens
were removed. Splenocytes were prepared and subsequently,
ELISA and CBA determined the amount of IFN- secreted
into the culture supernatant. IL-6/ mice had a more robust
IFN- response than did the C57BL/6j mice, with 2.5-fold
more IFN- secreted into the culture supernatant (Fig. 3A).
When splenocytes were preincubated with heat-killed Y. en-
terocolitica (HK Ye), the splenocytes from the C57BL/6j mice
showed a 13-fold increase in the amount of IFN- produced,
whereas the splenocytes from the IL-6/ mice stimulated with
HK Ye showed a 5-fold change compared to the IL-6/ un-
treated group. Treatment of the splenocytes from the C57BL/6j
or IL-6/ mice with concanavalin A (ConA) led to 10- and
5-fold increases in IFN-, respectively, compared to the un-
treated group. Increased levels of IFN- secreted by spleno-
cytes treated with HK Ye or ConA demonstrate that the cells
FIG. 2. IL-6/ mice have a hyperinflammatory response to Y. enterocolitica infection. C57BL/6j and IL-6/ mice were infected orally with 109
Y. enterocolitica. Infection was allowed to proceed for the indicated amount of time, and then tissues were prepared for histological analysis. Tissue
sections were stained with hematoxylin and eosin. (A) Image of an uninfected liver from a C57BL/6j mouse (magnification,200). (B) High-power
image (magnification, 200) of a liver from an IL-6/ mouse infected for 3 days. Note the fibrin thrombus (FT) and the resulting ischemic
necrosis (INC). (C) High-power image (magnification, 200) of a liver from a C57BL/6j mouse infected for 7 days. Note the fibrin thrombus (FT)
and the resulting ischemic necrosis (INC) compare to panel B. (D) Normal pancreas of a C57BL/6j mouse (magnification, 200). (E) Pancreas
of an IL-6/ mouse infected for 3 days. Note the neutrophilic inflammatory lesion (NI). (F) High-power image (magnification, 200) of a
pancreas of a C57BL/6j mouse infected for 3 days.
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are capable of responding to specific antigenic stimulation (HK
Ye) and a nonspecific mitogen (ConA). These data suggest a
specific response and argue against LPS tolerance as a reason
for the differences in cytokine levels. Differences in cytokine
levels due to differences in bacterial colonization of the spleno-
cytes were ruled out by enumerating the numbers of viable
bacteria in the spleens prior to use in the ELISAs. C57BL/6j
mice had between 3  108 and 7  108 CFU/g of spleen tissue,
whereas the IL-6/ mice had between 2.5  108 and 5  108
CFU/g of tissue, suggesting that the spleens had a similar bacte-
rial load.
The histopathologic examination suggested that the IL-6/
mice have a defect in the downregulation of the inflammatory
response to Y. enterocolitica. One cytokine that is involved in
the regulation of inflammatory responses and has recently
been shown to be involved in the downregulation of the in-
flammatory pathology of intestinal toxoplasmosis is TGF- (7).
Interestingly, it was observed that the administration of high
concentrations of recombinant TGF-1 provided limited pro-
tection to mice infected with Y. enterocolitica (3). To further
examine the molecular determinants of the inflammatory re-
sponse to Y. enterocolitica infection, single-cell splenocyte sus-
pensions were made from infected mice and cultured as de-
scribed above and then ELISA determined TGF-1 levels
(Fig. 3B). Interestingly, the splenocytes from C57BL/6j mice
showed a fourfold increased level of TGF-1 compared to
FIG. 3. Analysis of cytokine production by ELISA. (A) IFN- ELISA from the supernatant of splenocytes (105) of mice infected orally with
Y. enterocolitica. Splenocytes received the indicated treatment: no further treatment, 10 g of heat-killed Y. enterocolitica/ml, or 5 g of ConA/ml
for 3 days. The concentration of IFN- secreted into the culture supernatant was determined by sandwich ELISA according to the manufacturer’s
instructions. Splenocytes from C57BL/6j mice are represented by black bars, and those from IL-6/ mice are represented by white bars. (B)
TGF-1 ELISA from the supernatant of splenocytes (105 cells) of mice orally infected with Y. enterocolitica. The concentration of TGF-1 secreted
into the culture supernatant was determined by sandwich ELISA according to the manufacturer’s instructions. (C) IFN- ELISA. Splenocytes from
infected mice (C57BL/6j mice, IL-6/ mice, and IL-6/ mice treated with 1 g of rIL-6 SC every day for 5 days) were used for ELISA.
Splenocytes (105 cells) received the indicated treatment, i.e., no further treatment or 5 g of ConA/ml. The concentration of IFN- secreted into
the culture supernatant was determined by sandwich ELISA according to the manufacturer’s instructions. The asterisks indicate comparisons that
were not statistically significant. (D) TGF-1 ELISA. Mice were treated as described for panel C except that ConA was not added. Subsequently,
splenocytes (105) from these mice were cultured for 3 days. The concentration of TGF-1 secreted into the culture supernatant was determined
by sandwich ELISA according to the manufacturer’s instructions. The results are the average of four assays done in duplicate. The error bars
represent the standard deviation, and statistically significant comparisons (as determined by a Mann-Whitney nonparametric two-tailed ANOVA)
are indicated by brackets.
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splenocytes from the IL-6/ mice. The levels of IFN- and
TGF-1 appeared to be inversely related, suggesting a rela-
tionship. We were able to show a direct connection between
IL-6 and the levels of TGF- and IFN- by treating mice
during the course of infection with rIL-6 (Fig. 3C and D; see
also Tables 2 and 3). When IL-6/ mice were treated with
recombinant IL-6 (rIL-6) during the course of infection they
displayed a cytokine secretion profile that was most similar to
that of the wild-type mice. This suggests that the differences in
cytokine levels are due to the lack of IL-6 and not some other
defect in these animals. Taken together, high levels of IFN-
and low levels of TGF- could account for the hyper-inflam-
matory phenotype observed in the IL-6/ mice infected with
Y. enterocolitica.
Levels of the immunomodulatory cytokines IL-10, TNF-,
and MCP-1 are different in the IL-6/ mouse. Although sev-
eral lines of evidence implicated IFN-, TGF-1, and IL-1ra in
the IL-6 response to Yersinia infection, several other inflam-
matory cytokines are known to be involved in the resolution of
infection. Expression of these cytokines (IL-6, IL-10, MCP-1,
IFN-, TNF-, and IL-12p70) in splenocyte cultures from Y.
enterocolitica-infected IL-6/ and C57BL/6j mice were inves-
tigated. Mice were infected, and then serum and splenocyte
supernatants were harvested as described for the ELISA exper-
iments. Splenocytes cultured from infected tissues were then
subjected to CBA analysis to determine levels of cytokines (Ta-
bles 1 and 2). As described for the ELISA experiments, signif-
icantly higher levels of IFN- were observed in the splenocyte
cultures from IL-6/ mice compared to C57BL/6j mice.
Levels of TNF- were significantly elevated in the serum and
splenocyte supernatants of Y. enterocolitica-infected IL-6/
mice. The IL-6/ mice had between 7- and 17-fold more
TNF- in the serum and threefold more in splenocyte super-
natants. This is in good agreement with in vitro data with
human monocytes that demonstrated an IL-6-dependent sup-
pression of TNF- (27). High levels of TNF- in serum cor-
relate with endotoxic shock, which is consistent with the hy-
perinflammatory phenotype and histopathologic observations
of the IL-6/ mice.
MCP-1 is a CC chemokine that was recently shown to be
upregulated in response to the Invasin protein of Yersinia in
HeLa cells (18). Levels of MCP-1 were significantly increased
in the serum and splenocyte supernatants of Y. enterocolitica-
infected IL-6/ mice. IL-6/ mice had between 7- and 46-
fold more MCP-1 in the serum and 5-fold more MCP-1 in
splenocyte supernatants. Levels of both TNF- and MCP-1 in
serum increase over the course of infection and were present at
much higher levels in the sera of the IL-6/ mice.
Recent data suggest that IL-10 may have a role in the re-
sponse to Y. enterocolitica infection (29). Splenocyte cultures
from both C57BL/6j mice and IL-6/ mice produced detect-
able levels of IL-10, but the IL-6/ mice made significantly
more IL-10, and only in the sera of these mice was IL-10
detectable. The IL-6/ mice had 52-fold more IL-10 in
splenocyte supernatants. Splenocytes from both mouse strains
responded to stimulation by HK Yersinia or ConA by produc-
ing more MCP-1, IL-10, TNF-, and IFN-, and, in the case of
C57BL/6j mice, IL-6, suggesting that differences in cytokine
levels were not due to LPS tolerance. In none of the assays
performed was IL-12p70 detectable.
Levels of MCP-1, IL-10, TGF-1, and IFN- are related to
the presence of IL-6. To gain further insight into the relation-
TABLE 1. Cytokine levels in supernatants of splenocytes isolated from infected mice
Cytokine
Mean cytokine level (pg/ml) 
 SEMa in:
C57BL/6j mice IL-6/ mice IL-6/ mice  rIL-6
No Tx HK ConA No Tx HK ConA No Tx HK ConA
TNF- 710 
 51* 3,297 
 320 892 
 69 1,311 
 49* 6,450 
 229 2,029 
 40 266 
 5 1,538 
 51 567 
 26
IFN- 3 
 0.5* 1,250 
 377 1,034 
 100 17 
 2* 374 
 21 145 
 21 2 
 0.7 21 
 3 403 
 24
MCP-1 254 
 33* 1,767 
 167 1,325 
 359 1,263 
 62* 2,727 
 180 2,151 
 29 75 
 12 532 
 35 350 
 22
IL-10 15 
 7* 2,309 
 612 1,325 
 360 721 
 43* 4,900 
 869 1,893 
 171 14 
 8 231 
 24 52 
 3
IL-6 42 
 10 691 
 116 254 
 59 0 0 0 0 0 0
IL-12p70 0 0 0 0 0 0 0 0 0
a IL-6/ mice were treated with 1 g of rIL-6/day through the course of infection. No Tx, cultures that received no further treatment; HK, cultures that were treated
with 10 g of heat-killed Y. enterocolitica/ml; ConA, cultures that received 1 g of ConA/ml. An asterisk indicates a statistically significant comparison of at least P 	
0.02 as determined by Mann-Whitney ANOVA.
TABLE 2. Cytokine levels in sera of infected mice
Cytokine
Mean cytokine level (pg/ml) 
 SEMa at:
Day 0 Day 1 Day 3 Day 5 Day 7
C57BL/6 IL-6/ C57BL/6 IL-6/ C57BL/6 IL-6/ C57BL/6 IL-6/ IL-6/  rIL-6 C57BL/6 IL-6/
TNF- 9 8 17 
 2* 9 
 0.8* 11 
 1* 76 
 3* 13 
 4* 197 
 16* 92 
 28 25 
 4* 590 
 92*
IFN- 0 1.5 17 
 3* 6 
 1* 3 
 0.5* 16 
 5* 7 
 2* 31 
 2* 14 
 5 13 
 0.8* 40 
 9*
MCP-1 19 40 140 
 40 109 
 15 85 
 19* 642 
 70* 113 
 14* 887 
 95* 288 
 82 72 
 2* 3,643 
 1200*
IL-10 0 0 0 69 
 3 0 0 0 2,147 
 1320 811 
 475 0 154 
 66
IL-6 0 0 120 
 21 0 134 
 17 0 135 
 11 0 0 213 
 34 0
IL-12p70 0 0 0 0 0 0 0 0 0 0 0
a IL-6/ mice were treated with 1 g of rIL-6/day through the course of infection. An asterisk indicates a statistically significant comparison of at least P 	 0.02
as determined by Mann-Whitney ANOVA.
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ship between IL-6 and MCP-1, IL-10, TNF-, IFN-, and
TGF-1, IL-6/ mice were concurrently infected with Y. en-
terocolitica and injected with rIL-6. Subsequently, splenocytes
and sera were harvested, and cytokine levels were determined
by ELISA or CBA. Treatment of IL-6/ mice with rIL-6
resulted in a cytokine secretion profile that was most similar to
that of the C57BL/6j control mice (Fig. 3C and D and Tables
1 to 3). The rIL-6-treated IL-6/ mice had lower levels of
IFN-, MCP-1, IL-10, and TNF- and higher levels of TGF-1
than the mock-treated IL-6/ mice. Surprisingly, IL-6 was not
detectable in the sera of IL-6/ mice treated with rIL-6; this
could be due to a multitude of factors affecting the stability or
persistence of this cytokine in the serum or the fact that rHIL-6
was used to complement the IL-6/ mice and the ELISA and
CBA utilizes mouse monoclonal antibodies for detection. This
experiment links the expression of IFN-, MCP-1, IL-10,
TNF-, and TGF-1 with that of IL-6. Altogether, these data
suggested that IL-6 modulates the levels of several immuno-
modulatory cytokines in response to Y. enterocolitica infection
in vivo.
Although the levels of cytokines in serum are a good indi-
cation of systemic responses, they may not accurately represent
cytokine levels in microenvironments such as spleen tissue. To
determine whether there were differences between the cyto-
kine levels observed in the serum or in splenocyte culture and
those observed directly from spleen homogenates, we mea-
sured the levels of IL-6, MCP-1, IL-12p70, IFN-, and TNF-
directly from spleen homogenates (Table 3). As expected, the
concentration of cytokines was not identical but the trends
observed when cytokine levels were measured in the spleen
homogenates were the same as those observed from the serum
or splenocyte cultures. In the spleen homogenates, the IL-6/
mice had statistically significant (P 	 0.007) fourfold more
MCP-1 and twofold more IFN- than homogenates from the
C57BL/6j spleens. In this assay the differences in IL-10 and
TNF- were determined to not be statistically significant.
Whether cytokines are measured from splenocyte cultures,
serum, or spleen homogenates, it appears that the IL-6/
mice have a higher concentration of inflammatory cytokines
than the C57BL/6j mice. Furthermore, if mice are treated with
rIL-6 during the course of infection the cytokine profile more
closely resembles that of the C57BL/6j mouse. Altogether,
these data suggest that IL-6 plays a key role in balancing the
levels of pro- and anti-inflammatory cytokines during a Y. en-
terocolitica infection.
To determine whether the hyperinflammatory pathology ob-
served in the IL-6/ mice could be rescued by the adminis-
tration of rIL-6 during the course of infection, C57BL/6j mice,
IL-6/ mice, or IL-6/ mice treated with rIL-6 were infected
orally with 109 CFU of Y. enterocolitica, and the infection was
allowed to proceed for 3 days. The mice were then sacrificed,
and tissues were prepared for pathological analysis as de-
scribed above. Spleens were scored for inflammatory lesions in
a blind manner by two investigators (Table 4). When the in-
flammatory lesions of the spleens were examined, the IL-6/
mice treated with rIL-6 had lesions most similar to the lesions
observed in the C57BL/6j mice (Table 4). The IL-6/ had
more severe inflammatory lesions than either the IL-6/ mice
treated with rIL-6 or the C57BL/6j mice. Twenty percent of the
C57BL/6j mice and the IL-6/ mice treated with rIL-6 had
observable inflammatory changes in the spleen, whereas sixty
percent of the IL-6/ mice had inflammatory changes in the
spleen. Thus, based on spleen pathology, the addition of ex-
ogenous rIL-6 to IL-6/ mice was sufficient to rescue the
hyperinflammatory phenotype observed in the IL-6/ mice.
We did not attempt to rescue the lethality observed in the
IL-6/ mice by treating them with rIL-6, but this was success-
fully done in an L. monocytogenes infection of IL-6/ mice (12).
IL-6/ mice show a stronger cytotoxic response to Y. en-
terocolitica. The high levels of IFN- observed in the spleno-
cytes of Y. enterocolitica-infected IL-6/ mice are suggestive
of a stronger TH1 T-cell response. A stronger TH1 T-cell re-
sponse should lead to a more robust cytotoxic-T-lymphocyte
(CTL) response to Y. enterocolitica. To investigate the CTL
response in C57BL/6j and IL-6/ mice, the animals were
infected orally, and the infection was allowed to progress for 5
TABLE 3. Cytokine levels in spleen homogenates
Cytokine
Mean cytokine level (pg/ml) 
 SDa in:
C57BL/6j mice IL-6/ mice IL-6/ mice  rIL-6
TNF- 16 
 15 60 
 89 22 
 16
IFN- 83 
 23* 168 
 41 65 
 26
MCP-1 35 
 12* 130 
 81 46 
 34
IL-10 29 
 4 19 
 17 22 
 5
IL-6 58 
 18 ND ND
IL-12p70 ND ND ND
a Cytokine levels present in the spleen homogenate of infected mice were
determined by CBA. ND, no detectable cytokine. Asterisks indicate a statistically
significant result when C57BL/6j mice are compared to IL-6/ mice. Samples
were compared by using a Mann-Whitney test (P 	 0.007).
TABLE 4. Rescue of inflammatory pathologies in an IL-6/ mouse with rIL-6
Animala
Tissue score for:
% Spleens with pathology
Microabscessb Microcolonyc Inflammatory cell infiltrated Necrosis
C57BL/6j mice 1 (0.5) NA 2 (1.0) NA 20
IL-6/ mice 2.8 (0.83) 3 (0.5) 3 (1.0) 2 (0.16) 60
IL-6/ mice  rIL-6e 2.5 (1.0) NA 2 (1.0) NA 20
a The genetic background of the animals used is indicated. Animals were infected for 3 days with wild-type Y. enterocolitica, and then spleens were harvested for
investigation of the inflammatory pathologies.
b Microabscess refers to a defined inflammatory lesion without microscopically visible bacterial colonization. Lesions were scored as described in Materials and
Methods, and average scores for the spleens that had inflammatory pathology are reported. In parentheses is the fraction of inflamed spleens with the indicated
pathology.
c Microcolony refers to a defined inflammatory lesion with microscopically visible bacterial colonization.
d Inflammatory cell infiltrate refers to increased numbers of neutrophils and macrophages in the spleen compared to uninfected mice.
e To rescue the inflammatory pathology, IL-6/ mice received daily injections of 1 g of recombinant human IL-6 s.c.
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days. Mice were then sacrificed, and single-cell suspensions
were made from the spleens and MLN. Cell suspensions were
then added to peritoneal macrophages that were preincubated
with heat-killed Y. enterocolitica, and the percentage of cyto-
toxicity was determined enzymatically by measuring the release
of lactate dehydrogenase from the macrophage monolayer.
IL-6/ splenocytes or lymph node cells from IL-6/ mice
were four- to eightfold more cytotoxic than those of the
C57BL/6j mice (Fig. 4). When this experiment was performed
with cells from mice infected for 7 days, the same observations
were made. However, at day 7 the cells from the C57BL/6j
mice showed 30 to 40% cytotoxicity, whereas the IL-6/ cells
showed 75 to 95% cytotoxicity (data not shown).
DISCUSSION
The three pathogenic bacteria of the genus Yersinia, Y. en-
terocolitica, Y. pseudotuberculosis, and Y. pestis all cause signif-
icant disease in humans. In order to understand the pathogen-
esis of Y. enterocolitica infection, it is important to understand
the nature of the host response. We recently demonstrated a
key role for IL-1 in the initiation of intestinal inflammation in
response to Y. enterocolitica infection (14). Other researchers
have demonstrated a role for IL-1, IL-1ra, IL-6, IL-10, IL-12,
IL-18, TNF-, and IFN- in the resolution of Y. enterocolitica
infection or in in vitro models (2, 3, 5, 14, 15, 17, 29). Inter-
estingly, all of the cytokines identified to date function pre-
dominantly as enhancers of the inflammatory responses. With
the exception of IL-6, IL-1ra, and IL-10, no cytokines have yet
been identified that are involved in the downregulation of the
inflammatory response to Y. enterocolitica infection, and the
data presented here suggest that, in the context of an IL-6
deficiency, IL-10 is insufficient to decrease inflammatory re-
sponses. We have extended our investigation of the host in-
flammatory response to Y. enterocolitica infection to reexamine
the multifunctional cytokine IL-6 that appears to have a func-
tion in downregulating the inflammatory response to Y. entero-
colitica through the modulation of several pro- and anti-in-
flammatory cytokines.
When the first IL-6/ mice were produced, it was known
that the mice were immunocompromised and could not handle
bacterial or viral challenge as well as the wild-type controls
(22). IL-6 provides protection against the intracellular bacte-
rial pathogens L. monocytogenes and M. tuberculosis, and sev-
eral theories have been proposed to explain these deficiencies
(12, 23). Most theories relating to the role of IL-6 in the
control of bacterial infection have evolved around the func-
tioning of neutrophils. It is clear from the data presented here
that IL-6/ mice are defective in the control of a Y. entero-
colitica infection as well, and it is probable that there is a defect
in the neutrophil response to Y. enterocolitica since these mice
suffer from a rapid and overwhelming sepsis.
The pathological analysis suggests that inflammatory cells
are getting to the appropriate tissues in the infected IL-6/
mice. However, control of the infection is inadequate, as dem-
onstrated by both LD50 and kinetic analyses. The IL-6
/ mice
show early signs of severe sepsis. The combination of fibrin
thrombi in multiple organs and gastrointestinal bleeding sug-
gests that the mice are suffering from disseminated intravas-
cular coagulation a sign of severe sepsis. Interestingly, much of
the pathology that is observed in the IL-6/ mice is seen at
earlier time points than what is observed in the C57BL/6j mice.
For example, IL-6/ mice show rapid dissemination of Y. en-
terocolitica to the liver and spleen, suggesting again a defect in
innate immune responses. The exact role of IL-6 in innate
immunity remains unclear but, as previously demonstrated,
neutrophils have been shown to be the main source of IL-1ra
in response to Y. enterocolitica infection (17), and the down-
regulation of the IL-1-mediated inflammatory responses at the
site of infection may be a key role of IL-6.
Like IL-6, TGF-1 is a multifunctional cytokine that has an
important role in the regulation of inflammatory responses
(24). In fact, when TGF-1-deficient mice were produced it
was noted that these mice died 2 to 4 weeks after birth and that
they died of severe inflammatory responses (28). The severe
inflammatory response and early mortality make the direct
analysis of Y. enterocolitica infection in the TGF-1/ mice
impractical. More recently, it was noted that TGF-1 has a role
in the regulation of responses to infectious agents. The admin-
istration of rTGF-1 to mice infected with Y. enterocolitica
provides limited protection (3). Furthermore, in the murine
model of intestinal toxoplasmosis, TGF-1 controls intestinal
inflammatory responses to this pathogen by controlling IFN-
levels (7). The observed decrease in TGF-1 in IL-6/ mice
is consistent with the pathology we observed in these mice,
suggesting a role for TGF-1 in modulation of the inflamma-
tory cells during a Y. enterocolitica infection. In agreement with
the data on intestinal toxoplasmosis, the severe inflammatory
pathology appears to be related to the misregulation of inflam-
matory cytokines, including IFN-.
Splenocytes from infected C57BL/6j and IL-6/ mice had
different cytokine secretion profiles that appear to be inversely
related. The IL-6/ splenocytes had high levels of IFN-,
TNF-, MCP-1, and IL-10 and low levels of TGF-1, whereas
FIG. 4. Cytotoxicity assays. Single-cell suspensions were prepared
from the spleens and MLN of C57BL/6j and IL-6/ mice infected
orally with Y. enterocolitica for 5 days. Columns labeled with an “S”
represent the results from spleen cells, and columns labeled with and
“M” represent cells from the MLN. The cell suspensions (105 cells)
were cocultured with APCs (105 peritoneal macrophages) loaded with
10 g of heat-killed Y. enterocolitica for 4 h, and the amount of
cytotoxicity determined according to the manufacturer’s instructions.
The results are the averages of four assays done in duplicate. The error
bars represent the standard error of the mean, and statistically signif-
icant comparisons (as determined by a Mann-Whitney nonparametric
two-tailed ANOVA) are indicated by brackets.
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the C57BL/6j splenocytes showed lower levels of IFN-,
TNF-, MCP-1, IL-10, and higher levels of IL-6 and TGF-1.
The cytokine secretion profile and the hyperinflammatory phe-
notype of the IL-6/ mouse could be restored to that of the
wild-type control mice by treating the IL-6/ mice with rIL-6.
Consistent with the hypothesis that the cytokine secretion pro-
file is responsible for the hyperinflammatory phenotype, anti-
gen-stimulated splenocytes from IL-6/ mice were signifi-
cantly more cytotoxic than antigen-stimulated splenocytes
from C57BL/6j mice.
Much of the work investigating the role of IL-6 during bac-
terial infection has focused on the innate immune response.
However, it is also clear that there is a role for IL-6 in the
cellular immune response. Many of the pathologies observed
in the IL-6/ mice could also be accounted for by the overly
robust TH1 response. IFN- not only plays an important role in
polarizing CD4-T-cell responses, but it is also a key cytokine
for the activation of macrophages. The increase in IFN- in
IL-6/ mice can be explained by the recent observation that
IL-6 inhibits the TH1 polarization of CD4
 T cells (13). Be-
cause there is no IL-6 in these mice, this inhibition is lost,
leading to more IFN- and a more robust TH1 T-cell response
and probably a greater macrophage and CTL response. All of
these observations could account for the hyperinflammatory
response of the IL-6/ mice to Y. enterocolitica infection.
The inflammatory response to bacterial pathogens is clearly
an attempt by the host to resolve the infection before serious
disease can result. However, when the inflammatory response
is left unchecked the results are dire for the host. We provide
evidence in the present study that IL-6 has a protective role
during a Y. enterocolitica infection. The role of IL-6 in the
control of bacterial infections is most likely multifactorial, in-
volving both the innate and the cellular immune responses.
Because IL-6/ mice still have acute sepsis and are unable to
control the Y. enterocolitica infection we cannot rule out a
defect in the early innate responses, as suggested by other
investigators. However, we further suggest that a molecular
reason for the observed pathology of this infection involves the
modulation of IL-1ra (17), TNF-, MCP-1, IL-10, TGF-1,
and IFN- (the present study) in an IL-6-dependent fashion.
We have established a direct link between these cytokines and
IL-6 in vivo; these cytokines appear to be working in concert to
control the Y. enterocolitica infection and/or the inflammation
that results from the infection. It is the misregulation of these
cytokines in the IL-6/ mouse that leads to the hyperinflam-
matory phenotype observed in these mice. These data provide
further insight into the intricate nature of the host response to
bacterial pathogens and the complex nature of the immunomodu-
latory cytokines involved in the control of the infection. Alto-
gether, these data suggest that IL-6 may be a negative regula-
tor of the inflammatory response to Y. enterocolitica infection.
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